Correct me if I am wrong, Joseph, but this article "From Autism to Alzheimer's..." seems to be recent (i.e., last week) rather than five years ago. Assuming it is, this is a new support structure for Anavex' case on the MOA. I suspect it will be extremely interesting and useful fodder to be presented with their applications at the EMA and FDA.
News 
Market Data 
Discover 
AI
